v3.23.3
Commitments and Contingencies
12 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Off-Balance Sheet Arrangements
The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of September 30, 2023, the Company's only off-balance sheet arrangements consisted of $232.7 million of unfunded commitments, which was comprised of $205.6 million to provide debt and equity financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. Of the $205.6 million, approximately $154.2 million can be drawn immediately with the remaining amount subject to certain milestones that must be met by portfolio companies or other restrictions. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.
A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of September 30, 2023 and September 30, 2022 is shown in the table below:
September 30, 2023September 30, 2022
107-109 Beech OAK22 LLC$26,969 $— 
Delta Leasing SPV II LLC14,639 27,187 
BioXcel Therapeutics, Inc.14,547 11,785 
OCSI Glick JV LLC13,998 13,998 
Senior Loan Fund JV I, LLC13,125 35,000 
Fairbridge Strategic Capital Funding LLC13,090 22,150 
MND Holdings III Corp9,122 — 
Seres Therapeutics, Inc.8,090 — 
Assembled Brands Capital LLC7,514 2,008 
iCIMs, Inc.7,466 6,930 
Grove Hotel Parcel Owner, LLC5,286 4,293 
scPharmaceuticals Inc.5,212 — 
Kings Buyer, LLC5,189 1,537 
Avalara, Inc.5,047 — 
Mindbody, Inc.4,762 4,000 
Accupac, Inc.4,500 4,605 
107 Fair Street LLC4,227 — 
Harrow, Inc.4,011 — 
Inventus Power, Inc.3,792 — 
Dominion Diagnostics, LLC3,484 11,148 
Establishment Labs Holdings Inc.3,384 5,075 
OTG Management, LLC3,190 3,789 
PRGX Global, Inc.3,127 2,518 
Salus Workers' Compensation, LLC3,102 — 
ADC Therapeutics SA3,020 3,020 
Relativity ODA LLC2,762 2,218 
LSL Holdco, LLC2,650 427 
Spanx, LLC2,473 2,226 
Impel Pharmaceuticals Inc.2,458 — 
SCP Eye Care Services, LLC2,356 — 
112-126 Van Houten Real22 LLC2,343 — 
MRI Software LLC2,261 5,196 
Supreme Fitness Group NY Holdings, LLC2,199 1,527 
Tahoe Bidco B.V.2,162 1,741 
Coupa Holdings, LLC2,075 — 
Galileo Parent, Inc.2,061 — 
Oranje Holdco, Inc.1,904 — 
SIO2 Medical Products, Inc.1,821 — 
Pluralsight, LLC1,787 3,532 
Evergreen IX Borrower 2023, LLC1,626 — 
Berner Food & Beverage, LLC1,622 1,392 
PPW Aero Buyer, Inc.1,466 — 
Liquid Environmental Solutions Corporation1,383 1,115 
Acquia Inc.1,376 1,326 
Digital.AI Software Holdings, Inc.1,078 826 
Finastra USA, Inc.960 — 
MHE Intermediate Holdings, LLC821 1,429 
Telestream Holdings Corporation407 528 
Coyote Buyer, LLC400 1,333 
ASP-R-PAC Acquisition Co LLC396 — 
BAART Programs, Inc.— 8,645 
Marinus Pharmaceuticals, Inc.— 5,734 
RumbleOn, Inc.— 4,822 
Ardonagh Midco 3 PLC— 4,372 
Innocoll Pharmaceuticals Limited— 4,195 
Mesoblast, Inc.— 3,553 
Dialyze Holdings, LLC— 3,431 
Thrasio, LLC— 2,578 
Apptio, Inc.— 1,338 
CorEvitas, LLC— 915 
109 Montgomery Owner LLC— 477 
GKD Index Partners, LLC— 320 
Total$232,740 $224,239